早期宫颈癌双侧前哨淋巴结定位失败的危险因素
本研究基于SENTICOL I和II两项前瞻性试验的辅助分析,纳入2005至2012年法国28个肿瘤中心的405例FIGO IA-IIA期宫颈癌患者,评估临床、肿瘤及手术因素与双侧前哨淋巴结定位成功的关系。多因素分析显示,年龄≥70岁、肿瘤大小>20 mm和BMI>30 kg/m2与较低的双侧定位率显著相关,而高技能中心(>5例/年)和SENTICOL II研究阶段与较高的双侧定位率显著相关。
要点
- 年龄≥70岁、肿瘤>20 mm、BMI>30 kg/m2与双侧前哨淋巴结定位率降低显著相关。
- 高技能中心(>5例/年)和SENTICOL II阶段与双侧定位率升高显著相关。
- 总体至少一侧定位率94.1%,双侧定位率80.5%。
核心结论
- 早期宫颈癌中,年龄≥70岁、BMI≥30 kg/m2和肿瘤≥20 mm与较低的双侧前哨淋巴结定位率显著相关,而更丰富的前哨淋巴结活检技术经验可提高双侧定位率。
研究设计与样本
- 对SENTICOL I和II两项前瞻性试验的辅助分析,纳入2005至2012年法国28个肿瘤中心的405例FIGO IA-IIA期宫颈癌患者,采用蓝染料和同位素联合标记法检测前哨淋巴结。
主要发现
- 405例患者中,至少一侧盆腔前哨淋巴结识别381例(94.1%),双侧识别326例(80.5%)。
- 多因素分析显示,年龄≥70岁与较低的双侧定位率显著相关(ORa=0.02,95%CI=[0.001-0.28],p=0.004)。
- 肿瘤大小>20 mm与较低的双侧定位率显著相关(ORa=0.46,95%CI=[0.21-0.99],p=0.048)。
- BMI>30 kg/m2与较低的双侧定位率显著相关(ORa=0.28,95%CI=[0.12-0.65],p=0.003)。
- 高技能中心(>5例/年)与较高的双侧定位率显著相关(ORa=8.05,95%CI=[2.06-31.50],p=0.003);SENTICOL II(2009-2012)相比SENTICOL I(2005-2007)双侧定位率显著更高(ORa=2.6,95%CI=[1.23-5.51],p=0.01)。
临床怎么用
- 对于年龄≥70岁、BMI≥30 kg/m2或肿瘤>20 mm的早期宫颈癌患者,双侧前哨淋巴结定位失败风险较高,可据此预判并调整手术策略。
- 在高技能中心(>5例/年)进行前哨淋巴结活检可能提高双侧定位成功率。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this study was to determine clinical, tumoral and surgical factors associated with successful bilateral sentinel lymph node mapping (SBM) in early-stage cervical cancer. METHODS: We performed an ancillary work on the data of two prospective trials on SLN biopsy for FIGO IA-IIA cervical cancer (SENTICOL I & II). Patients having Sentinel lymph node (SLN) mapping for early-stage cervical cancer were included between 2005 and 2012 from 28 French oncologic centers. SLN was detected by a combined labeling technique (blue and isotopic). RESULTS: 405 patients were included for analysis: SLNs were identified on at least one side of the pelvis in 381 patients (94.1%) and bilaterally in 326 patients (80.5%). The mean age was 45.4 years [22-85 years]. Most patients had IB1 pathologic FIGO 2018 stage (81.3%) and squamous cell carcinoma (71%). Surgeries were mainly performed by minimally invasive approach (368 patients - 90.9%). By multivariate analysis, lower SBM rate was significantly associated with Age ≥70 years (ORa = 0.02, 95%CI = [0.001-0.28], p = 0.004), tumor size larger than 20 mm (ORa = 0.46,95%CI = [0.21-0.99], p = 0.048) and Body-mass index higher than 30 kg/m2 (ORa = 0.28, 95%CI = [0.12-0.65], p = 0.003). SBM rate was significantly higher in high skills centers (>5patients/year) (ORa = 8.05, 95%CI = [2.06-31.50], p = 0.003) and in SENTICOL II (2009-2012) compared to SENTICOL I (2005-2007) (ORa = 2.6, 95%CI = [1.23-5.51], p = 0.01). CONCLUSIONS: In early-stage cervical cancer, bilateral SLN detection rates is lower in patients aged more than 70years, patients with BMI≥30 kg/m2 and larger tumor ≥20 mm whereas stronger experience of SLN biopsy technique improves bilateral SLN detection.
引用
- Balaya V, Bresset A, Guani B, et al. Risk factors for failure of bilateral sentinel lymph node mapping in early-stage cervical cancer. Gynecol Oncol. 2019. PMID: 31839343. doi:10.1016/j.ygyno.2019.10.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。